XD5-19906-70756
4 vaccinations
1 coded response
20 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 151 / PA
- Registered
- 2021-11-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-20
Dose 1 — Pfizer-BioNTech
-
2021-05-11
Dose 2 — Pfizer-BioNTech
-
2021-11-30
Registered in v-safe
-
2021-11-30
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-11-30
-
2021-12-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-12-02
- 2021-12-03
- 2021-12-04
- 2021-12-05
- 2021-12-06
- 2021-12-07
- 2021-12-15
- 2021-12-21
- 2021-12-28
- 2022-01-04
- 2022-01-11
- 2022-03-01
- 2022-05-31
-
2022-09-07
Dose 4 — Pfizer-BioNTech
- 2022-10-09
- 2022-10-12
- 2022-10-19
- 2022-12-10
-
2023-03-08
Survey response — 6 months, dose 4MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-20 | Pfizer-BioNTech | No |
| 2 | 2021-05-11 | Pfizer-BioNTech | No |
| 3 | 2021-11-30 | Pfizer-BioNTech | Flu |
| 4 | 2022-09-07 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release